With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...

The Federal Government has trained scientists drawn from key research institutions across the country on mRNA technology ...

Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns ...

A black-box warning is not a neutral informational update. It is the FDA’s most aggressive regulatory communication via product labeling, intended to alert clinicians and patients to risks so grave ...

The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed ...

As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development.

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

The Coalition for Epidemic Preparedness Innovations said it will invest $54.3 million with Moderna to fund a Phase 3 trial of ...

The co-founder of SCIMaP looks at the year of NIH cuts — and what they say about the future of American research.

Changing just one atom in a COVID-19 vaccine lipid redirects delivery from the liver to the spleen, improving tumor ...

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...